BeStock  
Stocks › Biotechnology › OCS

Oculis OCS

US equityMarket cap rank #3711Biotechnology
$8.50 −$0.22 (-2.52%)
Pre-market · Oct 8, 7:40 am ET · After hours $8.50 0.00%
Open$8.83
Prev close$8.72
Day range$8.35 – $8.83
Volume173.7K
Market cap$523.50M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±1.6%last 9 reports
Closed higher6 of 967% of the time
Best reaction+2.4%
Worst reaction-6.9%

Stock move on the day after each report

+1.5%2024/Q2-0.5%2024/Q3+0.5%2024/Q4+1.5%2025/Q1+0.3%2025/Q2-0.1%2025/Q3+0.5%2025/Q4-6.9%2026/Q1+2.4%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q26 Aug 2026After Market–+2.42%–
2026/Q111 May 2026After Market±18.7%-6.86%Within range
2025/Q43 Mar 2026After Market–+0.54%–
2025/Q310 Nov 2025After Market–-0.10%–
2025/Q221 Aug 2025After Market–+0.28%–
2025/Q18 May 2025Pre Market–+1.52%–
2024/Q411 Mar 2025Pre Market–+0.55%–
2024/Q37 Nov 2024Pre Market–-0.53%–
2024/Q227 Aug 2024After Market–+1.51%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Discussion

No comments yet — be the first to weigh in on OCS.

Leave a comment

Scroll to Top